Stay updated on Pembrolizumab + Imprime PGG in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s UI/version marker was bumped from “v3.5.2” to “v3.5.3,” indicating a site revision update rather than a change to the clinical study information.
    Difference
    0.0%
    Check dated 2026-04-25T05:22:46.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T03:27:37.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.0. The previous revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-20T03:27:18.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the page's revision history.
    Difference
    0.0%
    Check dated 2026-03-12T20:27:08.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2 (replacing Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T01:42:07.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision label changed from v3.4.0 to v3.4.1 on the page; no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:32:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Imprime PGG in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.